Auto-Injected Testosterone May Address Some TRT Shortcomings

Auto-Injected Testosterone May Address Some TRT Shortcomings

CHICAGO—Testosterone replacement therapy (TRT) using an auto injector to self-administer testosterone subcutaneously once-weekly maintains testosterone levels in a clinically...

Long-Term Benefit for Stereotactic Radiation in Prostate Cancer

Long-Term Benefit for Stereotactic Radiation in Prostate Cancer

(HealthDay News) -- For men with low- and intermediate-risk prostate cancer (PCa), stereotactic body radiation therapy (SBRT) seems safe and effective in the long term,...

Radiation Ups Survival When PCa Metastatic Burden Is Low

Radiation Ups Survival When PCa Metastatic Burden Is Low

Prostate radiation therapy does not improve overall survival in men with newly diagnosed metastatic prostate cancer (PCa), except for those with a low metastatic burden,...

'Real-World' Study Characterizes PCa Active Surveillance

'Real-World' Study Characterizes PCa Active Surveillance

CHICAGO—Real-world evidence from a large contemporary cohort of men on active surveillance (AS) for prostate cancer (PCa) provides reassurance that disease characteristics are...

Prostate Cancer Linked to Greater Fat, Fatty Acid Intake

Prostate Cancer Linked to Greater Fat, Fatty Acid Intake

Greater intake of some fatty acids is associated with a higher risk of prostate cancer (PCa), with the risk increasing along with consumption, according to a new study. The...

PDE5 Inhibitor Use Doesn't Cause Melanoma

PDE5 Inhibitor Use Doesn't Cause Melanoma

(HealthDay News) — Use of phosphodiesterase type 5 (PDE5) inhibitors does not appear to increase the risk of melanoma, according to the conclusions of a meta-analysis published...

 Erectile Dysfunction May Predict Development of Parkinson's Disease

Erectile Dysfunction May Predict Development of Parkinson's Disease

Erectile dysfunction (ED) is associated with a higher risk of developing Parkinson's disease, according to a new study. In a population-based retrospective cohort study using...

Maximal Tumor Diameter Predicts PSA Failure Risk

Maximal Tumor Diameter Predicts PSA Failure Risk

ORLANDO—Maximal tumor diameter (MTD) may predict which prostate cancer patients are at very low risk of PSA failure following radical prostatectomy who may not benefit from...

ADT May Be Safely Deferred After PSA Relapse

ADT May Be Safely Deferred After PSA Relapse

Immediate androgen deprivation therapy (ADT) offers little or no survival benefit over deferred ADT to prostate cancer patients who experience PSA-only relapse after radical...

New Findings May Explain PSA Bounce

New Findings May Explain PSA Bounce

Transient elevations in PSA values after prostate cancer radiotherapy—known as PSA bounce—may be the result of late damage to healthy prostatic tissue, researchers reported at...

Lower PSA Predicts Favorable Salvage Radiotherapy Outcomes

Lower PSA Predicts Favorable Salvage Radiotherapy Outcomes

Lower PSA and shorter PSA doubling times prior to salvage radiotherapy (RT) for prostate cancer after primary radical prostatectomy are associated with favorable biochemical...

 Palpable Tumors Plus Low PSA May Up Prostate Cancer Death Risk

Palpable Tumors Plus Low PSA May Up Prostate Cancer Death Risk

Among men with palpable prostate cancer (PCa) and normal-range PSA level at diagnosis, the risk of cancer-related death increases as PSA level decreases, a new study...